A coordinated specialty care model can most effectively address early psychosis, but it’s also important to involve the patient and their family members when making treatment decisions, according to Jacob Ballon, MD, MPH, clinical associate professor, psychiatry and behavioral sciences, Stanford University.
A coordinated specialty care model can most effectively address early psychosis, but it’s also important to involve the patient and their family members when making treatment decisions, according to Jacob Ballon, MD, MPH, clinical associate professor, psychiatry and behavioral sciences, Stanford University.
Transcript
What is the ideal coordinated team model to support those with early psychosis or at high risk for psychosis?
Well, the evidence would show that a coordinated specialty care model is the best model for treatment of early psychosis. That again comes from the RAISE-ETP study which has shown that there’s a distinct benefit to having an interdisciplinary team provide care for patients. This includes having psychiatrists, case workers, psychologists, family therapists, supportive education and employment specialists, and peer specialists all part of the team.
Why is shared decision making and collaboration important when supporting people experiencing psychosis?
Shared decision making is important because we want to make sure that we’re in partnership with our patients. This is a chronic illness and people are gonna need to be involved in their care throughout their life. Simply telling people what to do is not a way to keep people involved, and so we need to be understanding of all the different stakeholders at play. So that means getting the patient perspective, it means getting the parent’s perspective or other family members, understanding the full context of their life.
Everybody in the room is an expert in the treatment, not just the psychiatrist, and to simply tell people what they have to do is not a way that they’re going to want to partner for the long term.
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
VBID, Heading Into a Third Decade, Looks to Promote Personalization and Access
March 12th 2025Speakers at the 2025 Value-Based Insurance Design summit recapped the accomplishments made over the past 20 years in designing insurance benefits with value in mind and looked ahead to iterations to come.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Advancing HIV Care With Doravirine and Islatravir: Q&A With Amy Colson, MD, MPH
March 12th 2025New data from the MK-8591A-051 and MK-8591A-052 trials, both investigating the efficacy and safety of 100-mg doravirine and 0.25-mg islatravir as a once-daily 2-drug regimen for virologically suppressed people living with HIV-1, were presented today by Amy Colson, MD, MPH.
Read More
Implementation, Adherence to DoxyPEP Remains Low in At-Risk Groups
March 12th 2025Patients in Washington D.C. and San Francisco had minimal early uptake and adherence to doxycycline post-exposure prophylaxis (DoxyPEP) in studies presented at the Conference on Retroviruses and Opportunistic Infections 2025.
Read More